Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 telaprevir combination study in genotype 1 hepatitis C prior nonresponders
2006-004665-33Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of telaprevir in hepatitis C virus infection (4 arms), sponsored by Vertex Pharmaceuticals. Primary endpoint: Sustained viral response. Started Feb 2007; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2006-004665-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004665-33.